The Coronary Artery Bypass Grafts Market is witnessing steady growth as cardiovascular diseases continue to remain one of the leading causes of mortality worldwide. Coronary artery bypass grafting (CABG) is a critical surgical procedure used to improve blood flow to the heart in patients suffering from severe coronary artery disease (CAD). With the increasing prevalence of lifestyle-related cardiovascular conditions, the demand for advanced surgical solutions and devices used in CABG procedures is expanding globally. Medical technology companies and healthcare providers are focusing on developing innovative graft materials and surgical tools to improve patient outcomes and reduce complications.

According to recent industry analysis, the Coronary Artery Bypass Grafts market size is expected to reach US$ 28.88 billion by 2033 from US$ 16.94 billion in 2025. The market is estimated to record a CAGR of 6.89% from 2026 to 2033. This growth is driven by the rising incidence of coronary artery disease, the growing elderly population, technological advancements in cardiac surgery, and increasing healthcare expenditure in emerging economies.

Rising Prevalence of Coronary Artery Disease Globally

One of the most significant factors fueling the expansion of the Coronary Artery Bypass Grafts Market is the rising global prevalence of coronary artery disease. Sedentary lifestyles, unhealthy dietary habits, obesity, diabetes, smoking, and stress are major contributors to cardiovascular disorders. As these risk factors become more common across both developed and developing nations, the number of patients requiring surgical interventions such as CABG continues to grow.

Coronary artery disease occurs when the arteries supplying blood to the heart become narrowed or blocked due to plaque buildup. In advanced cases, CABG surgery becomes necessary to restore proper blood flow. This growing patient pool is increasing the demand for graft materials, surgical instruments, and advanced cardiac technologies. Healthcare systems across the globe are investing in improving cardiac care infrastructure, which further contributes to the growth of the Coronary Artery Bypass Grafts Market.

Growing Geriatric Population Drives CABG Demand

Another important factor driving market growth is the rapidly expanding geriatric population. Older adults are more susceptible to cardiovascular diseases due to age-related physiological changes and prolonged exposure to risk factors. As life expectancy continues to increase worldwide, the number of elderly individuals requiring cardiac procedures is also rising.

CABG surgery remains one of the most effective treatments for severe coronary artery blockages in elderly patients. Hospitals and cardiac care centers are witnessing a steady increase in CABG procedures performed on aging populations. This trend is creating strong demand for reliable graft materials, surgical stabilizers, retractors, and heart positioning devices used during bypass surgery.

Additionally, improvements in surgical safety and post-operative care have made CABG procedures safer for older patients, encouraging healthcare providers to recommend surgical intervention when necessary. As a result, the growing geriatric population is expected to remain a major driver for the Coronary Artery Bypass Grafts Market over the coming years.

Advances in Graft and Surgical Techniques

Technological advancements in cardiac surgery and graft development are significantly transforming the Coronary Artery Bypass Grafts Market. Researchers and medical device manufacturers are continuously developing improved graft materials that offer better durability, reduced rejection risk, and enhanced compatibility with human tissues.

Modern surgical tools such as heart positioners, tissue stabilizers, and advanced retractors are helping surgeons perform CABG procedures with greater precision and efficiency. These innovations reduce surgical complications and improve recovery times for patients.

Additionally, the growing adoption of minimally invasive techniques and off-pump CABG procedures is revolutionizing the cardiac surgery landscape. Off-pump CABG eliminates the need for a heart-lung machine, reducing complications associated with traditional on-pump surgery. Such technological developments are increasing the success rates of bypass surgeries and encouraging hospitals to adopt advanced surgical systems.

Market Segmentation

The Coronary Artery Bypass Grafts Market is segmented based on product, surgical procedure, technology, and end user.

By Product:

• Grafts
• Retractors
• Heart Positioners
• Tissue Stabilizers
• Other Products

Grafts represent one of the most essential components used in bypass surgeries, as they create alternate pathways for blood flow around blocked arteries. Meanwhile, devices such as heart positioners and tissue stabilizers assist surgeons in maintaining stability during complex procedures.

By Surgical Procedure:

• Single CABG Surgery
• Double CABG Surgery
• Triple CABG Surgery
• Quadruple CABG Surgery

The choice of surgical procedure depends on the number of coronary arteries that require bypass. Triple and quadruple CABG surgeries are often performed in patients with severe arterial blockages.

By Technology:

• On-Pump CABG
• Off-Pump CABG
• Other Technologies

On-pump CABG remains widely used, but off-pump CABG procedures are gaining popularity due to reduced complications and shorter recovery periods.

By End User:

• Hospitals
• Cardiology Clinics
• Research Institutes
• Other End Users

Hospitals account for the largest share of the market due to the availability of advanced surgical infrastructure and specialized cardiac care teams.

Market Leaders and Key Company Profiles

The Coronary Artery Bypass Grafts Market is highly competitive, with several leading medical technology companies focusing on innovation, strategic collaborations, and product development to strengthen their market positions.

Key players operating in the market include Medtronic plc, Terumo Corporation, Getinge AB, LivaNova PLC, Edwards Lifesciences Corporation, Boston Scientific Corporation, Abbott Laboratories, B. Braun Melsungen AG, MAQUET Holding B.V. & Co. KG, and Teleflex Incorporated.

These companies are investing heavily in research and development to create advanced graft technologies and surgical devices that enhance procedural efficiency and patient outcomes. Strategic partnerships with hospitals and research institutes are also helping companies expand their global presence.

Future Outlook

The future of the Coronary Artery Bypass Grafts Market looks promising as cardiovascular diseases continue to rise globally. Growing awareness about heart health, improvements in healthcare infrastructure, and technological innovations in cardiac surgery are expected to drive sustained market growth.

Furthermore, the integration of robotics, AI-assisted surgical planning, and advanced biomaterials is likely to revolutionize CABG procedures in the coming years. As healthcare providers focus on improving surgical outcomes and reducing patient recovery time, the demand for advanced bypass graft technologies will continue to expand.

With increasing investments in cardiac care and the rising burden of heart diseases, the Coronary Artery Bypass Grafts Market is poised to experience significant growth and innovation through 2033.

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

Contact us:

• If you have any questions about this report or would like further information, please contact us:
• Contact person: Ankit Mathur
• Email: sales@businessmarketinsights.com
• Phone: +16467917070